Is this 17% yielding FTSE 250 share worth owning?

Our writer owns a FTSE 250 share with a mouth-watering dividend yield of 17%. But its business faces problems. Should he just dump the shares?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

As an investor with an appetite for dividends, when I own a share with a juicy yield it makes me happy. So the fact that I own a well-known FTSE 250 share with a monster dividend yield of 17% might sound like cause for celebration.

Often though, a yield that high is a red flag that a dividend cut might be on its way. So, is this share one worth holding in my portfolio?

Self-made problems

The share in question is Jupiter (LSE: JUP).

It has been a tough time for asset managers and a lot of rivals have seen their shares fall. Abrdn, for example, has seen its shares plummet 44% over the past year. But I think Jupiter is suffering from some bad choices of its own making, not just the general problems currently facing many asset managers.

An example is Jupiter’s close involvement with investment trust Chrysalis. The latter’s shares have fallen 72% in the past year. Its exposure to unquoted companies has brought its valuations under scrutiny. That seems to have been a distraction for Jupiter and has helped to drag its share price down 62% in the past year.

As the Jupiter share price has fallen, its dividend yield has moved up. It now offers the biggest yield of any company in either the FTSE 250 or FTSE 100!

Trouble at t’mill

My concern, though, is that the dividend may be cut.

At the interim level, Jupiter maintained its payout at the same level as last year. But business performance was alarming. Compared to the same period last year, net management fees fell 11% and statutory profit before tax crashed 68%. Over the six months, assets under management fell by 19%. Partly that reflects market returns that are affecting many asset managers. But it also came about because Jupiter saw net cash outflows of £3.6bn across the period.

It means that Jupiter fundholders are pulling about £140m a week more from its funds than they are putting into them. The company’s fall in earnings in the first half already alarmed me. But if the net outflow of client funds continues, I think earnings could slide even further. The 7.9p per share interim dividend was nowhere near being covered by basic earnings per share for the six months of 2.6p.

If Jupiter cannot turn its business performance around quickly I think it will likely have to cut its dividend in future.

FTSE 250 high yielder

Despite that, I continue to be attracted to the company and hold it in my portfolio.

The mammoth current yield means that even after a dividend cut, Jupiter could be an attractive income pick compared to many other FTSE shares. Although its business has stumbled, it retains key assets, such as a well-known brand. It needs to figure out how to get more investors putting money into its funds. It has been able to do that in the past, which gives me some confidence it can do it again in future.

The battered share price reflects many investors’ deep worries about what happens next at Jupiter. I recognise the risks involved, but continue to see an investment case for the fund manager. I think the share is worth me still owning, although I am increasingly expecting a dividend cut.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

C Ruane has positions in Jupiter Fund Management and abrdn. The Motley Fool UK has recommended Jupiter Fund Management. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »